- Making News: Washington State's Never-Ending Gubernatorial Recount
Six weeks after Election Day, the dead heat for Governor of the State of Washington may be broken. Trailing by only 261 votes, out of 2.9 million cast, Democrat Christine Gregoire had demanded a recount, which left her only 42 votes behind GOP candidate Dino Rossi. Late yesterday, Gregoire took the lead for the first time, by the incredibly thin margin of 8 votes. David Postman has been following the story for the Seattle Times.
- Reporter's Notebook: FDA Approves Macugen for Age-Related Vision Loss
Relief is on the way for Americans who suffer from "age-related macular degeneration," an aging process that can cause blindness. Although last week's Celebrex headlines overshadowed the news, the Food and Drug Administration Friday approved a new drug that has been proven to slow vision loss. Steven Schwartz of UCLA's Jules Stein Eye Institute sits on the Scientific Advisory Board of Eyetech Pharmaceuticals, the company that developed Macugen.
FROM THIS EPISODE
President Bush has pushed Social Security reform to the top of his national agenda, suggesting at least partial privatization. It was an ingenious plan at the time of its inception in the 1930's. Workers would pay a tax to benefit those already retired and as subsequent employees retired, the work force would pay taxes to care for them. But now, the retiree-to-worker ratio has skyrocketed, a shift many experts fear bodes ill for those entering the labor market. While some economists call it a crisis of our times, others contend that simple adjustments will right the system for decades to come. Guest host Diana Nyad discusses the possible revamping of Social Security and what that might look like for people of all ages, with economists from Princeton University and the Center for Economic and Policy Research, an analyst from the Cato Institute, a public trustee of the Social Security Fund and a former official of the Federal Reserve.